loading...| Preferred Name |
Rivastigmine Tartrate |
|
| Synonyms |
Carbamic Acid, Ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl Ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1) RIVASTIGMINE TARTRATE SDZ-ENA 713 Rivastigmine Tartrate Exelon |
|
| Definitions |
The tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47707 |
|
| Accepted_Therapeutic_Use_For |
Alzheimer's disease; dementia associated with Parkinson's disease |
|
| CAS_Registry |
129101-54-8 |
|
| CHEBI_ID |
CHEBI:64358 |
|
| Chemical_Formula |
C14H22N2O2.C4H6O6 |
|
| code |
C47707 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
The tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function. |
|
| FDA_UNII_Code |
9IY2357JPE |
|
| FULL_SYN |
Carbamic Acid, Ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl Ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1) RIVASTIGMINE TARTRATE SDZ-ENA 713 Rivastigmine Tartrate Exelon |
|
| Has_Free_Acid_Or_Base_Form | ||
| label |
Rivastigmine Tartrate |
|
| Legacy Concept Name |
Rivastigmine_Tartrate |
|
| NCI_Drug_Dictionary_ID |
779007 |
|
| PDQ_Closed_Trial_Search_ID |
779007 |
|
| PDQ_Open_Trial_Search_ID |
779007 |
|
| Preferred_Name |
Rivastigmine Tartrate |
|
| prefixIRI |
Thesaurus:C47707 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0772415 |
|
| subClassOf |